Filter posts

Ensuring the Safety and Commercial Success of Biosimilars in the United States

The forthcoming arrival of biosimilars into the U.S has spurred debate over the approaches that …

How to Drive International Innovation: Scientific American Worldview

Which countries are winning the innovation game? Will the U.S. maintain its leadership position in …

State of the Biotech Industry: Burrill's Biotech 2013 Report

To open his Super Session at the 2013 BIO International Convention, G. Steven Burrill, CEO …

Ernst & Young's Beyond Borders: Matters of Evidence

Hundreds of attendees turned out to glean insights from findings outlined in Ernst & Young …

Convention Veterans Putting the “Super” in Super Sessions

Featured in the BIO Buzz Center at last year’s Convention, two of our Super Session …

BIO 2012 Super Session Recap: Burrill State-of-the-Industry Report

“How are we doing? It’s tough.” That’s what G. Steven Burrill, CEO of Burrill & …

2011 BIO International Convention Super Sessions

2011 BIO International Convention Super Sessions Focus on State of the Industry C-Level speakers lead …